Education
About Us
Working with TipRanks
Follow Us
Francis Tavares Insider Profile
4 Followers
Francis Tavares, Chief Technology Officer at PreveCeutical Medical, holds 1.00M shares in PreveCeutical Medical (Ticker: PRVCF). Most recently, Francis Tavares Bought 256,000 shares of PreveCeutical Medical on Sep 04, 2025 for an estimated value of $9.22K.
Francis Tavares PreveCeutical Medical (PRVCF)Chief Technology Officer
PreveCeutical Medical (PRVCF)
Chief Technology Officer
Ranked #50,028 out of 103,606 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+2.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Francis Tavares's holdings
Insider Roles
Chief Technology Officer
Roles that Francis Tavares holds in companies
Most Profitable Insider Trade
The most profitable trade made by Francis Tavares
Francis Tavares's Trading History
List of latest transactions for each holding click on a transaction to see Francis Tavares's performance on stock
You May Also Like
Francis Tavares insider profile FAQ
What is the percentage of profitable transactions made by Francis Tavares?
The percentage of profitable transactions made by Francis Tavares is 50%.
What is the average return per transaction made by Francis Tavares?
The average return per transaction made by Francis Tavares is 2.60%.
What stocks does Francis Tavares hold?
Francis Tavares holds: PRVCF stocks.
What was Francis Tavares’s latest transaction?
Francis Tavares latest transaction was an Informative Buy of $9.22K.
What was Francis Tavares's most profitable transaction?
Francis Tavares’s most profitable transaction was an Informative Buy of PRVCF stock on September 4, 2025. The return on the trade was 19.00%.
What is Francis Tavares's role in PreveCeutical Medical?
Francis Tavares's role in PreveCeutical Medical is Chief Technology Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.